StockData
Lyell Immunopharma, Inc. logo

Lyell Immunopharma, Inc. (LYEL) stock

LYELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$13.89+0.22 (+1.61%)

Close on Nov 18, 2026Market cap $340.38MP/E –Yield –

Lyell Immunopharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Lyell Immunopharma's price to sales ratio was 9.5× on Jan 31, 2024, against 20.8× a year earlier. Over the last 3 years it ranged from 6.0× to 445.5×, with a median of 28.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 20249.5×−0.6
2023Dec 29, 202310.1×−12.0
2022Dec 30, 202222.1×−160.9
2021Dec 31, 2021183.0×–

More Lyell Immunopharma figures

See a number that looks wrong?